Medicsight Announces New Global Marketing Partnership with Ziosoft Unveiled at...( NEW YORK Nov. 25 /- Medicsight PLC a ...),Health

NEW YORK, Nov. 25 /PRNewswire/ -- Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (Amex: MGT), and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software, today announced a new global partnership with Ziosoft Inc ("Ziosoft"), a leading developer of 3D advanced visualization and analysis technology. Combined Ziosoft-Medicsight products for the detection of colorectal polyps will be distributed through the Ziosoft network.

Both companies are presenting at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America, which is being held in Chicago, 30 November until 5 December 2008. The companies are demonstrating the first results of the partnership at the Ziosoft booth (#7957).

Ziosoft is a market leader for 3D workstations. In 2007 the company had an install base of more than 1,500 3D systems. The companies are working together to integrate Medicsight's ColonCAD(TM) with Ziosoft's Ziostation, and the product is due for global launch early in 2009. U.S. launch will follow the product's clearance by the U.S. Food and Drug Administration, also expected in early 2009.

David Sumner, Chief Executive of Medicsight, said: "The partnership with Ziosoft is part of our ongoing strategy to build a broad base distribution channel, which will enable us to quickly penetrate global markets. Global demand for CT colonography looks set to increase dramatically, with clinical evidence such as the recently published U.S. National CT Colonography Trial (ACRIN 6664) demonstrating the positive benefits of CTC as a screening procedure for the early detection of colorectal cancer."

"This is the ideal time for Ziosoft to partner with Medicsight," said Mark Koeniguer, COO of Ziosoft. "There is great demand from the
'/>"/>